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Urinary tract infections (UTIs) have complex dynamics, with uropathogenic Escherichia coli (UPEC), the
major causative agent, capable of colonization from the urethra to the kidneys in both extracellular and
intracellular niches while also producing chronic persistent infections and frequent recurrent disease. In
mouse and human bladders, UPEC invades the superficial epithelium, and some bacteria enter the cytoplasm
to rapidly replicate into intracellular bacterial communities (IBCs) comprised of 104 bacteria each. Through
IBC formation, UPEC expands in numbers while subverting aspects of the innate immune response. Within
12 h of murine bladder infection, half of the bacteria are intracellular, with 3 to 700 IBCs formed. Using mixed
infections with green fluorescent protein (GFP) and wild-type (WT) UPEC, we discovered that each IBC is
clonally derived from a single bacterium. Genetically tagged UPEC and a multiplex PCR assay were employed
to investigate the distribution of UPEC throughout urinary tract niches over time. In the first 24 h postinfection
(hpi), the fraction of tags dramatically decreased in the bladder and kidney, while the number of CFU
increased. The percentage of tags detected at 6 hpi correlated to the number of IBCs produced, which closely
matched a calculated multinomial distribution based on IBC clonality. The fraction of tags remaining there-
after depended on UTI outcome, which ranged from resolution of infection with or without quiescent intra-
cellular reservoirs (QIRs) to the development of chronic cystitis as defined by persistent bacteriuria. Signif-
icantly more tags remained in mice that developed chronic cystitis, arguing that during the acute stages of
infection, a higher number of IBCs precedes chronic cystitis than precedes QIR formation.
Population bottlenecks exist for many infections and are
particularly well documented during transmission between
hosts for RNA viruses and parasites (1, 3, 27, 28, 35, 41).
Localizing bottlenecks in time and space during an infection
can identify steps in pathogenesis where an organism encoun-
ters the strongest barriers to establishing a foothold within a
host. Bottlenecks may also represent important steps in host
colonization and pathogenesis to target with therapeutics. Sim-
ilar studies have been undertaken to identify genes important
for tissue colonization and transit between tissues for bacterial
pathogens (7, 36, 37). Several potential bottlenecks limiting the
progression of uropathogenic Escherichia coli (UPEC) to later
stages of infection exist in the pathogenic cascade of urinary
tract infections (UTIs): (i) invasion of the superficial bladder
epithelium, (ii) avoidance of Toll-like receptor 4 (TLR4)-me-
diated expulsion (46), (iii) persistence in the face of superficial
facet cell exfoliation, (iv) the maturation process of intracellu-
lar bacterial communities (IBCs), (v) ascension from bladder
to the kidneys, and (vi) possible descent from kidneys to the
bladder. These population dynamics all occur in the face of
clearance mechanisms, including micturition and the innate
immune system (38). Understanding these bottlenecks in the
setting of mucosal infection of the urinary tract will provide
insight into the pathogenesis of this complex infection with the
goal to develop better treatments.
UTIs are painful, expensive to the individual and society,
and will affect 50% of women during their lifetime (12). The
vast majority of community-acquired UTIs are caused by
UPEC. The clinical diagnosis of UTI hinges upon the ability to
culture bacteria from clean-catch urine samples. When the
uropathogen is sensitive to the chosen agent, oral antibiotics
typically produce a rapid improvement in symptoms and ster-
ilization of the urine (15, 16). Despite appropriate treatment of
a primary UTI, 25 to 40% of adult women will have at least one
recurrence (rUTI) within 6 months of her initial infection (33,
45). Additionally, up to 20% of women may experience the
symptoms of cystitis, or infection of the bladder, with accom-
panying urine cultures from clean-catch specimens below the
diagnostic cutoff of 105 CFU/ml (13). This implies that bac-
terial occupation of urinary tract niches even in the absence of
clinical diagnosis can contribute to symptoms of UTI. The
exact location of bacteria within the urinary tract in these
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syndromes is, at present, unknown. The high prevalence of
UTI, frequent repeated antibiotic therapy for rUTI, and the
failure to use stringent diagnoses of UTI may drive rising
antibiotic resistance (15–17). Through a thorough examination
of the molecular basis for rUTI and the identification of the
major persistent reservoirs for UPEC within the urinary tract,
new therapeutic strategies may be designed to eliminate UPEC
from the urinary tract and thus better guide appropriate anti-
biotic usage.
Current knowledge of the pathogenesis of UPEC UTI is
incomplete, but accumulated molecular studies demonstrate
tremendous complexity in the pathogenesis of the disease. In
most primary UTIs, UPEC is thought to ascend the urethra
from the perineum to colonize the bladder lumen. Addition-
ally, UPEC can ascend the ureters and colonize the kidneys.
Increased vesicoureteral reflux (VUR) enhances the likelihood
of bacterial ascension into the kidneys and subsequent renal
scarring in children and individuals with neurogenic bladders
(32). Through studies in a murine model of UTI, several novel
intracellular pathways within the bladder important for UPEC
pathogenesis have been elucidated. After experimental trans-
urethral inoculation of UPEC into the urinary tract, UPEC
invades the superficial facet cells of the bladder in a type 1
pilus-dependent manner (29, 34, 38). In order to evade expul-
sion from these cells via a TLR4-dependent mechanism (46),
UPEC must escape into the cell cytoplasm, where it rapidly
replicates and aggregates into cytosolic clusters of bacteria
called intracellular bacterial communities (IBCs), a process
that occurs independent of specific host genotypes (2, 14).
After full maturation of the IBCs, UPEC becomes filamentous
and flux out of the superficial facet cell in response to a TLR4-
dependent host signal (25). The luminal bacteria may then
invade other superficial facet cells, renewing the invasion and
intracellular replication cascade (24, 25). Thus, UPEC under-
goes at least two rounds of IBC formation over the first 24 h
postinfection (hpi). Occupation of an intracellular niche by
UPEC is not unique to the mouse model, as IBCs and fila-
mentous bacteria have been frequently identified in urine from
women with acute cystitis (42). Replication within epithelial
cells may protect UPEC from being cleared by neutrophils,
antimicrobial peptides, micturition, and antibiotic administra-
tion (4, 25). In the C3H/HeN mouse model of UTI, the IBC
stage is most active during the first 24 hpi (24). Thus, during
UTI, many niches within the urinary tract are colonized, in-
cluding the bladder lumen, cells of the bladder epithelium, and
the kidneys.
IBCs are not typically observed in C3H/HeN mice after 48
hpi. However, outcomes of the infection are dependent on the
immune response to acute events (20). The C3H/HeN mouse
model of UTI recapitulates several of the outcomes present in
humans. The outcome of bladder infection in these mice is
bimodal, with 20 to 40% of infected C3H/HeN mice develop-
ing persistent bacteriuria and chronic cystitis (20). Placebo-
controlled trials have demonstrated persistent bacteriuria in
women with or without resolution of symptoms in the absence
of antibiotic treatment (11, 33). High levels of interleukin 5
(IL-5), IL-6, keratinocyte cytokine (KC), and granulocyte col-
ony-stimulating factor (G-CSF) in the serum of C3H/HeN
mice at 24 hpi are nearly 100% predictive of ensuing chronic
cystitis (20). The remaining mice have low levels of these cy-
tokines and resolve the acute infection, evidenced by sterile
urine. However, even upon resolution of bacteriuria, UPEC
may occupy niches in the underlying epithelium in quiescent
intracellular reservoirs (QIRs) (40). Thus, UTI pathogenesis
has complexity in both space (tissue niche) and time. During
the acute stages of pathogenesis, IBC formation facilitates the
expansion of bacterial numbers in the face of innate defenses.
A multitude of consequences to the acute events exist, ranging
from resolution of infection with or without accompanying
QIRs to ensuing chronic cystitis or pyelonephritis. The rela-
tionship between IBC formation during acute infection and the
subsequent outcome of infection is not known. The dynamics
of acute infection and the subsequent outcomes may also be
altered if the kidneys are infected concurrently with the blad-
der. Underlying conditions, such as vesicoureteral reflux
(VUR), increase the likelihood of coinfection of the kidneys
and bladder. These complicated population dynamics may be
modeled in specific mouse strains, such as C3H/HeN. These
mice are also susceptible to kidney infection due to a high rate
of VUR (21, 22, 43, 47).
With all of the transitions UPEC makes between anatomic
and cellular spaces, it is likely that only a fraction of the total
bacterial population transitions from one niche to another, in
which case population bottlenecks likely occur. Based on the
complexity of UTI and the various niches UPEC inhabits dur-
ing infection, we sought to determine transit between relevant
niches and barriers within the urinary tract over time and
whether the penetration of infection barriers resulted in an
expansion of those descendants. A prior study indicated that
intracellular UPEC makes up a significant proportion of the
bacteria in the bladder during the first 48 hpi, as determined by
ex vivo gentamicin protection assays (38). Early in infection,
micturition and neutrophil influx may disproportionately re-
duce or eliminate luminal bacteria, while intracellular UPEC is
largely protected from these clearance mechanisms.
We addressed the role of bottlenecks in UPEC population
dynamics during UTI using a panel of 40 unique genetically
tagged isogenic UPEC isolates that were tracked using a mul-
tiplex PCR assay. We modeled the dynamics of population flux
using a calculated multinomial distribution and compared the-
oretical values to a complicated model of infection using the
C3H/HeN mouse, which is susceptible to VUR, thus resulting
in UPEC being distributed during acute infection in the blad-
der and kidneys. In the bladder, we demonstrated that each
IBC arises from replication of a single invasive bacterium and
that the number of IBCs present at 6 hpi strongly correlates
with the number of unique tags present. In mice that would
likely resolve bacteriuria and/or develop QIRs, the fraction of
uniquely tagged UPEC decreased to 10 to 20% of the number
of tags present in the initial inoculum during the first 24 hpi in
whole-bladder specimens. In contrast, in mice with persistent
bacteriuria, a hallmark of chronic cystitis, nearly 60% of
unique tags remained. Thus, a high number of IBCs formed at
6 hpi and/or an inability to clear bacteria from the bladder
lumen preceded chronic cystitis. Utilizing ex vivo gentamicin
protection assays to separate intracellular and extracellular
bladder populations, we found that during acute UTI, the
majority of remaining clones occupied all niches within the
urinary tract, while later in infection disparate clonal popula-
tions existed independently in the bladders or kidneys.
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Construction of 40 isogenic tagged UPEC isolates. Unique tags were inserted
into the chromosome following the ybhC gene in the region of the lambda phage
attachment site of the clinical isolate UTI89 (39). This site was chosen since prior
insertions in this region (gfp reporter fusions) did not adversely affect pathogen-
esis (49). The tags were designed using unique sequences as reported by Lehoux
et al. (30, 31). Primer sequences are shown in Table S1 in the supplemental
material. For the construction of the genomic insertion cassettes, the chloram-
phenicol or kanamycin cassette from pKD3 or pKD4 (10) was amplified using
primer BP-1 in combination with BP-2A, BP-2B, and BP-2C. The respective
products were digested with EcoRI and column purified (Qiagen). Each of the
BP-00F primers was phosphorylated in a reaction that included 1 T4 ligase
buffer (NEB), 10 mM dATP (Promega), and 1 U of T4 polynucleotide kinase
(Invitrogen) for 30 min at 37°C. The appropriate BP-00F and BP-00R primers
were annealed by mixing equal molar ratios in distilled water (dH2O), heating to
95°C for 5 min, and cooling slowly to room temperature (RT). In a similar
method, primers BP-5 and BP-6 were annealed to each other. A tripartite
ligation was performed using the BP-1/BP-2-digested PCR products with the
annealed products of BP-00F/R and BP-5/BP-6 in 1 T4 ligase buffer and 10 U
of T4 ligase for 1 h at RT. To a PCR mixture containing 1 Pfx buffer (Invit-
rogen), 2 mM MgSO4, 0.2 mM deoxynucleoside triphosphate (dNTP), 2.5 U of
Pfx polymerase (Invitrogen), 200 pmol each of primers BP-1 and BP-6, and 0.5
l of each ligation were added. The reactions were cycled at 94°C for 3 min
followed by 30 cycles of 94°C for 15 s, 55°C for 45 s, and 68°C for 1.5 min. A final
extension at 68°C for 7 min was performed. The 1.6-kb products were verified
by gel electrophoresis and column purified (Qiagen). Chromosomal insertion of
the tag constructs was performed using the Red recombinase method (10). The
tags were verified by colony PCR in a reaction mixture containing 1  PCR
buffer (Invitrogen) with 0.2 mM dNTP, 2.5 mM MgCl2, 2.5 U Taq polymerase
(Invitrogen), and 200 pmol each of the appropriate primer pairs, BP-8K (kana-
mycin template) or BP-8C (chloramphenicol template) and BP-00F. Growth
curves of each individual strain were performed to ensure no gross growth
defects in broth culture (data not shown).
Evaluation of isogenic UPEC strains in a murine cystitis model. In prepara-
tion for inoculation into mice, each of the 40 isogenic UTI89 derivatives was
grown individually in LB statically at 37°C overnight and then subcultured
1:1,000 into 2 ml of fresh LB with static growth at 37°C for 18 to 24 h. Cell density
was measured using an optical density at 600 nm (OD600) value, and each clone
was added in approximately equal cell numbers to a central pool. The pooled
bacteria were centrifuged for 10 min at 6,500  g at 4°C. The pellet was resus-
pended in 20 to 25 ml of sterile phosphate-buffered saline (PBS) to yield a final
cell suspension in which 50 l contained 1  107 to 2  107 CFU. Fifty
microliters was introduced over 10 s into 7- to 8-week-old C3H/HeN mice under
2.5% isofluorane inhalation via a transurethral route. The infections were al-
lowed to proceed for 1 h to up to 4 weeks, at which time the mice were sacrificed
under anesthesia, and the bladders and kidneys were removed and homogenized
in 1 ml and 0.800 ml sterile PBS, respectively. Homogenates were serially diluted
and plated to enumerate the bacteria in the tissues. Genomic DNA was obtained
from the bacterial lawns by the addition of 2 ml of sterile water in each petri dish
and scraped using a bacterial cell scraper (BD Falcon). The bacteria were
pelleted by centrifugation and washed with PBS. The final pellet was processed
using the Promega genomic DNA isolation kit per the manufacturer’s instruc-
tions. Genomic DNA was also prepared from a bacterial pellet of the pooled
input inoculum.
BAR-PATH multiplex PCR was performed using 50 ng of genomic DNA in a
PCR mix, including 1 Taq buffer (Invitrogen), 2.5 mM MgCl2, 0.2 mM dNTP,
100 pmol each of BP-8C and BP-8K, and 2.5 U Taq DNA polymerase (Invitro-
gen). The BP-00F primers (see Table S1 in the supplemental material) were
mixed in sets of 3 primers for inclusion in PCRs (BP-01F, BP-02F, BP-03F and
BP-04F, BP-05F, BP-06F, etc.) and added to the reaction mixture at final con-
centrations of 66.6 pmol/primer. Reactions were cycled with a hot start and
then at 94°C for 3 min followed by touchdown PCR with 10 cycles of 94°C for
30 s, 62°C for 30 s with a 1°C decrease per cycle, and 72°C for 30 s. Next, 30 cycles
were performed at 94°C for 15 s, 55°C for 15 s, and 72°C for 30 s. A final 7-min
extension at 72°C was performed. Ten microliters of the 25 l reaction was run
on a 2.5% Tris-borate-EDTA (TBE)-agarose gel. The presence or absence of an
individual strain in the multiplex PCR was determined by eye in comparison to
the intensity of its cognate band in the inoculum. If a strain was not detected in
the inoculum pool, it was not included in the analysis for that experiment.
Thirty-seven of the 40 tags were routinely detected in the inoculum. Three tags
were statistically underrepresented in the PCR of the inoculum pool and were
thus excluded in the subsequent analyses of the endpoint samples. Ambiguous
bands were analyzed in an independent multiplex PCR replicate. All mouse
infection studies were approved by the Animal Studies Committee of Washing-
ton University in St. Louis, MO.
IBC enumeration. To quantify the number of IBCs per bladder, bladders were
bisected and splayed onto sterile silica plates and fixed with 3% paraformalde-
hyde (Sigma). The bladders were washed 3 times with 2 mM MgCl2 (Sigma),
0.01% Na deoxycholate (Sigma), and 0.02% Nonidet P-40 (Roche) in sterile
PBS, pH 7.4. Bladders were then stained in 0.4 ml of 25 mg/ml X-Gal (5-bromo-
4-chloro-3-indolyl--D-galactopyranoside; Sigma) and a solution containing 1
mM potassium ferrocyanide and 1 mM potassium ferricyanide (Sigma). After
incubating at 30°C for 16 h, bladders were visualized under a dissecting micro-
scope, where IBCs appeared as bright blue punctate circles.
Confocal laser scanning microscopy. Female 6- to 7-week-old C3H/HeN mice
were infected with a 1:1 or 1:50 mixture of UTI89 and UTI89::HKGFP and
sacrificed at 6 or 12 hpi (49). Bladders were extracted, splayed, and counter-
stained with TO-PRO-3 and imaged with a Zeiss LSM410 confocal laser scan-
ning microscope.
Ex vivo gentamicin protection assay. At the indicated times postinfection,
bladders were removed aseptically and bisected twice. The bladders were washed
three times with 500 l sterile PBS. The washes were pooled, spun at 500 rpm for
5 min, and dilution plated as described earlier. This wash was termed “luminal”
or “extracellular.” The bladders were then incubated for 90 min with 100 g/ml
gentamicin to kill adherent extracellular bacteria. After this incubation, the
bladders were washed twice with 1 ml sterile PBS. The bladder was then homog-
enized in 1 ml sterile PBS and dilution plated to enumerate intracellular CFU.
Bacterial pellets were obtained and processed as described earlier.
RESULTS
IBCs arise from a single invasive bacterium. UPEC invades
the superficial facet cells of the bladder 15 min to 1 h postin-
oculation into the urinary tract as determined by ex vivo gen-
tamicin protection assays (48). Over the next 8 to 12 h, IBC
formation ensues for bacteria that have successfully invaded
and escaped into the cytosol of the superficial facet cells (24).
To address whether IBCs contain a clonal population ex-
panded from a single bacterium or an aggregate of multiple
distinct founders, we performed coinfections of mice with 1:1
and 50:1 ratios of unlabeled and green fluorescent protein
(GFP)-marked isogenic UPEC (49). Six hours postinfection,
mice were euthanized, and the bladders were splayed, fixed,
and stained with TO-PRO-3 and examined by confocal micros-
copy. As a result, the unlabeled UPEC IBCs appeared red and
the GFP-marked UPEC IBCs appeared yellow-green. Of the
approximately 500 IBCs examined, each was exclusively red or
yellow-green, regardless of the inoculation ratio (Fig. 1). When
superficial facet cells contained more than one IBC derived
from a different inoculating strain, a clear demarcation existed
such that no bacterial mixing occurred (Fig. 1C and D), indi-
cating that IBCs are clonal formations arising from a single
invasive bacterium.
Formation of IBCs strongly correlates to tag diversity.
Given that each IBC is derived from a single bacterial founder
and IBC formation is rare, with only 0.01 to 0.001% of the
initial inoculum successfully undergoing IBC formation, we
anticipated that various bottlenecks restricting invasion and
subsequent IBC formation may result in a significant founder
effect in later stages of infection. At 6 hpi following an initial
inoculation of 1  107 to 5  107 UPEC CFU, each mouse
bladder contained between 3 and 700 IBCs (median, 49.5;
geometric mean, 40) (Fig. 2), consistent with previously re-
ported data for C3H/HeN mice (5, 8, 44). Combining prior
knowledge that the bacterial population is primarily intracel-
lular at 12 hpi (38, 39) with the finding that IBCs are clonal, we
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hypothesized that the invasion and IBC formation cycle acts as
a strong population bottleneck that restricts overall bacterial
diversity and may subsequently contribute a significant propor-
tion of bacteria populating later stages of infection. In order to
test this hypothesis, we designed 40 isogenic strains of UTI89,
each with a unique 100- to 300-bp genetic sequence inserted
into the  phage region of the genome (see Materials and
Methods). Bacteria containing these unique tags were identi-
fied using 8 multiplex PCRs. We reasoned that the small num-
ber of clonal IBCs relative to the total inoculum, which was
primarily intracellular by 12 hpi (38), may contribute to a
founder effect in the number of unique genotypes arising from
this early bottleneck event.
We infected mice with a pool of the tagged strains in equal
proportions. At 6 hpi, the mice were sacrificed and the infected
bladders were splayed and stained with X-Gal to detect bac-
terial beta-galactosidase and thus localize UPEC in mature
IBC formations, which stained punctate purple. Following
enumeration of IBCs, the bladders were homogenized, and
genomic DNA was extracted from the bacteria present in the
bladder. We found a broad range of unique bacterial signa-
tures corresponding to the range of IBCs formed per bladder
at 6 hpi (Fig. 2, black squares). Based on the hypothesis that
the bacteria contained in IBCs account for the majority of
bacteria in the bladder at 6 hpi, we calculated the fraction of
tags that most likely would be remaining relative to the number
of IBCs present using a multinomial distribution (Fig. 2, line).
Superimposition of the theoretical multinomial distribution
onto the experimental data revealed a close fit (see Discussion
and the supplemental material). The five data points marked
with asterisks in Fig. 2 represent bladders that contained more
tags than IBCs. The increased fraction of tags in these bladders
likely represented invasion events of bacteria that had not yet
replicated into a mature IBC and thus not yet discerned in the
X-Gal-stained bladders but were detected by the more sensi-
tive multiplex PCR assay. For mice whose bladders contained
100 IBCs at 6 h, all 40 tags were present. These data suggest
that early in infection, the clonal IBC populations, arising from
a small number of bacterial founders, may contribute the ma-
jority of bacterial diversity to later stages of infection.
Bacterial diversity decreased dramatically in the bladders
and kidneys over time. During the most acute stages of isolated
cystitis, the formation of IBCs, each from a single invasive
bacterium and coincident with luminal clearance of bacteria,
would be anticipated to constitute a stringent bottleneck, lim-
iting the genetic diversity of organisms progressing to later
stages of infection. We first determined the overall dynamics of
infection using our set of 40 uniquely tagged UPEC strains as
a proxy for bacterial diversity to understand the occupation of
the urinary tract over time. We infected C3H/HeN mice with
1  107 to 5  107 total CFU (2.5  105 to 1.25  106
CFU/unique strain) and tracked them over the course of 4
weeks. At the designated times after infection, the bladders
and kidneys were homogenized, and 6% of the sample was
plated to enumerate CFU (Fig. 3A and B). Through this ap-
proach, rare abundance tags are likely amplified to above the
limit of detection in the multiplex PCR assay. A tag comprising
20 CFU in the sample could potentially be lost with this
method, but such rare abundance tags are not likely to persist
within the urinary tract for an extended period of time.
Total bacterial diversity in the bladder decreased signifi-
cantly over the first 24 hpi (P  0.003, 1 hpi versus 24 hpi) to
a median plateau of 25 to 40% of the initial tags remaining
(Fig. 3C), while the number of CFU increased over this same
time period to 105 CFU (Fig. 3A). The simultaneous reduction
in tag diversity with an increase in the number of CFU oc-
curred during the time in which IBCs formed, suggesting a
relationship between the IBC bottleneck and a founder effect
in populating the bladder. Bacterial diversity in the kidneys
also decreased over this same time span (P  0.003, 1 hpi
versus 24 hpi), with approximately the same fraction of tags
present in the bladders and kidneys by 1 week postinfection
(wpi) (Fig. 3D).
FIG. 2. IBC number correlates with the number of tags present.
C3H/HeN mice were infected as described and processed to enumer-
ate IBCs and extract bacterial genomic DNA (see Materials and Meth-
ods). Black squares represent the number of IBCs and the number of
tagged strains present per mouse bladder. The line is the median
number of tags expected based on a multinomial distribution of IBC
number (see Discussion and the supplemental material). Data repre-
sent 3 independent experiments, with 5 to 10 mice per experiment. *,
bladders with a greater number of tags than IBCs.
FIG. 1. IBCs are clonal and derived from a single invasive bac-
terium. C3H/HeN mice were coinfected with UTI89 and
UTI89::HKGFP and sacrificed at 6 hpi and 12 hpi. Bladders were
aseptically removed, splayed, and imaged with confocal microscopy.
(A and B) IBCs in whole mount at 6 hpi, counterstained with
TO-PRO-3. Each image shows the merged red and green channel
data. (C and D) Coresident IBCs inside a single superficial facet cell
at 12 hpi. Representative images of over 500 independent IBCs are
shown.
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IBC formation correlates with the outcome of infection. In
C3H/HeN mice, the fate of disease is determined within the
first 24 h of infection (20). The two disease outcomes of res-
olution of bacteriuria concomitant with the establishment of
QIRs and the development of persistent bacteriuria indicative
of chronic cystitis result in a bimodal distribution of bacterial
CFU within the bladder that occurs after 1 week (22). Thus, we
investigated the relationship between the number of IBCs
formed early in infection and the impact on the fraction of tags
remaining later in infection and disease outcome (20, 40).
We infected 20 mice with equal proportions of the 40
uniquely tagged UTI89 strains and determined the number of
bacterial CFU and the number of unique tags that remained at
2 wpi. Mice were stratified based on their urine titers over time
and their 2-wpi bladder titers. Chronic cystitis was categorized
by persistent bacteriuria of 104 CFU/ml at 1, 3, 7, 10, and 14
dpi and a 2-wpi bladder titer of104 CFU (20). The remaining
mice were classified based on bladder titers of 104 CFU and
at least one urine collection over the 2-week infection that
contained 104 CFU/ml UPEC (Fig. 4A and B). Mice that
developed persistent bacteriuria and chronic cystitis had sig-
nificantly more unique UPEC signatures present in the bladder
by 2 wpi than mice that resolved infection (Fig. 4C). Based on
the founder effect theory, this would argue that development
of chronic cystitis is correlated with increased IBC formation
during the acute stage of infection, which is consistent with the
strong correlation between IBC formation and the fraction of
tags present throughout the bladder during the IBC cycle (Fig.
2). Conversely, decreased IBC formation is more likely corre-
lated with resolution of bacteriuria with reservoir bladder titers
of 104 CFU.
Population dynamics in acute versus chronic infection. UTI
is a dynamic infection sometimes entailing concomitant kidney
infection. Populations of UPEC within the bladders and kid-
neys of C3H/HeN mice may thus be shaped by different inde-
pendent environmental forces, including unique bottlenecks.
These physically separated populations may subsequently in-
termix to generate some intermediate, combined population.
Abundant influx of neutrophils and immune mediators into the
bladder occurs very early during UTI in both mice and humans
(21, 23, 26). Invasion of the bladder epithelium may represent
a mechanism for UPEC to increase its population during UTI
while remaining separated from much of the innate immune
response. Gentamicin protection assays on ex vivo-infected
bladders support this concept, demonstrating that by 12 hpi in
murine UTI, the majority of UPEC CFU is intracellular (38).
On the basis of these prior studies, we sought to determine the
location of UPEC within urinary tract niches throughout in-
fection. In order to obtain a more complete understanding of
how bacterial subpopulations are distributed within the urinary
FIG. 3. Bacterial diversity decreased dramatically during the first 24 hpi. At the indicated times postinfection, C3H/HeN mice were sacrificed,
the bladder and kidneys were removed aseptically and homogenized in PBS, and 6% of the homogenate was plated to enumerate CFU in the
bladders (A) and kidney pairs (B). Genomic DNA was isolated from a lawn of UPEC isolated from the tissue homogenates, and multiplex PCR
was conducted to determine the fraction of the 40 unique tags present in each bladder (C) and kidney pair (D). CFU data are presented as
CFU/whole organ. Bars are median values. n  1 to 2 experiments, with 5 to 8 mice each. P values were calculated using a two-tailed
Mann-Whitney nonparametric comparison. An initial experiment conducted with 43 tags is also included in this analysis.
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tract at a given time, sampling of different niches within the
urinary tract was performed using mice infected with equal
numbers of each of the 40 genetically tagged UTI89 strains at
different times postinfection. We obtained clean-catch urine
from mice by gentle suprapubic pressure and plated it to enu-
merate CFU (Fig. 5A). Afterwards, the mice were sacrificed,
and the bladder was bisected twice and washed with sterile PBS
to liberate loosely bound and planktonic UPEC CFU, hereto-
fore referred as the “luminal” or “extracellular” fraction (Fig.
5B). The intact, quadrisected bladder was incubated with the
antibiotic gentamicin, which does not penetrate the bladder
epithelium, thus selectively eliminating extracellular organ-
isms. After the gentamicin was washed away, the bladder tissue
was homogenized to liberate the intracellular bacteria, desig-
nated the “gentamicin-protected bladder” population (Fig.
5C). During the first 24 hpi, this fraction represented bacteria
that invaded superficial facet cells and were, in some cases,
within IBCs. After 48 hpi, when IBC formation no longer
occurs, the gentamicin-protected fraction consisted of bacteria
within QIRs or another niche protected from gentamicin. Kid-
neys were also homogenized and plated to enumerate CFU
(Fig. 5D).
All of the 40 uniquely tagged UPEC strains were present in
both the extracellular and intracellular populations at 1 hpi
(Fig. 5F and G). This amount of tag diversity was not statisti-
cally different from that observed in the whole bladder at 1 hpi
(Fig. 3C; P  0.05, Wilcoxon signed-rank test; hypothetical
median  1.0). At 6 hpi, the proportion of genetic tags ap-
proached 1 in the kidneys, likely due to VUR of the inoculum
in the C3H/HeN mice at the initiation of the infection. How-
ever, the proportion of genetic tags was decreased in the urine
and all compartments of the bladder (Fig. 5F and G), while
host innate defenses have been shown to be induced and en-
gaged (23). The data reconfirmed that only 0.1 to 1% of inva-
sive events lead to the formation of an IBC, perhaps as a result
of TLR4-mediated bacterial expulsion (46). Furthermore, the
wide range of unique tags present in the intracellular compart-
ment at 6 hpi (Fig. 5G) corresponded with the natural varia-
tion in IBC number between mice, correlating with our earlier
results (Fig. 2).
Between 6 and 24 hpi, the bacterial tags detected in the
kidneys decreased (Fig. 5H). However, the tags detected in the
bladder lumen and intracellular bladder fractions increased
(Fig. 5F and G), suggesting that the overall bacterial diversity
of the bladder was increasing due to shedding of bacteria
carrying independent, unique tags from the kidney. In order to
understand the overlap of bacteria in different niches, the
identities of each tag were determined in each niche at each
time point. We then determined on a per-mouse basis the
fraction of unique and shared tags present within and between
the following niches: urine, bladder lumen, bladder epithelium,
and kidneys. For each time point, we determined the fraction
and identity of each tagged strain present in each of the 15
possible overlapping and distinct niche combinations out of the
total number of tags present within the urinary tract (Fig. 5I to
M). At 6 hpi, the kidneys and urine contained 34% of bacterial
FIG. 4. Higher fraction of unique bacterial signatures remains in mice experiencing chronic cystitis. (A) Two weeks postinfection, C3H/HeN
mice were sacrificed, and the bladders were removed aseptically, homogenized, and plated to enumerate CFU. (B) Urine samples were obtained
by gentle suprapubic pressure and plated to enumerate CFU. The dashed line at 104 CFU represents the limit for assessing the presence of UTI
in clean-catch urine samples (40). Urine titers above this point are considered bacteriuria indicative of a UTI, while bladder titers greater than this
cutoff indicate chronic cystitis. (C) Genomic DNA was then obtained from the bacteria from each bladder sample, and multiplex PCR was
conducted. Bars are median values. P values were calculated using a two-tailed Mann-Whitney nonparametric comparison.
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FIG. 5. Niche-specific diversity over time demonstrates population dynamics throughout UTI. At the indicated times postinfection, urine was
obtained via gentle suprapubic pressure and plated to enumerate CFU (A) and the fraction of tags remaining (E). A gentamicin protection assay
was performed to enumerate luminal CFU (B) and the fraction of tags remaining (F) and gentamicin-protected CFU (C) and tags remaining (G).
Kidneys were also plated to enumerate CFU (D) and tags remaining (H). The niche occupation of specific tags was determined and is represented
as the average fraction of tags present in distinct and overlapping niches (15 total permutations) and displayed as a 4-set Venn diagram at 6 hpi
(I), 24 hpi (J), 1 wpi (K), 2 wpi (L), and 4 wpi (M). Each percentage listed displays the fraction of tags present in that unique or shared niche out
of the total number of tags in each murine urinary tract. Data for panels A to H represent 1 to 3 experiments, with 5 mice per time point. Data
for panels I to M represent experiments where kidney information was available: 2 experiments with 4 or 5 mice for panel I and 1 experiment with
5 mice each for panels J to M. *, the niche combination with the greatest unique diversity present. Bars are median values. P values were calculated
using a two-tailed Mann-Whitney nonparametric comparison.
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diversity not present in a bladder niche, likely reflecting the
population that gained access to the kidney earlier in the in-
fection as a result of VUR. At 24 hpi, 38% of the total tagged
strains still present within the urinary tract were shared be-
tween all of the compartments (Fig. 5J). These data show that
at 24 hpi, the majority of individual clones of bacteria are
populating every niche within the urinary tract, likely as a
result of emergence from IBCs earlier in infection and descent
from the kidneys to seed other niches of the urinary tract.
By 48 hpi, the CFU in the bladder stratified into a bimodal
distribution reflecting the development of persistent bacteri-
uria and bladder titers of 104 CFU or resolution of bacteri-
uria and establishment of QIRs with UPEC titers of104 CFU
(20, 40). The bimodal distribution was evident in the bladder
lumen and gentamicin-protected fractions at 1 wpi (Fig. 5C).
At 2 wpi in this experimental set, bacteria were no longer
present in the lumen and urine in 4/5 of the mice and instead
exclusively occupied gentamicin-protected reservoirs within
the bladder epithelium or kidney (Fig. 5L). At 1 wpi, among
the mice with high bladder bacterial counts indicative of
chronic cystitis, 21% of the tags were shared in all niches. In
contrast, 15% of the tags remaining in mice that resolved
bacteriuria and formed QIRs were located exclusively in a
gentamicin-protected niche, which increased to 28% of all uri-
nary tract diversity by 4 wpi (Fig. 5K and M). The majority of
tags at 4 wpi (60%) were present only in the urine without a
bladder or kidney niche colonized, potentially suggesting that
these bacteria colonized the ureter, urethra, or periurethral
area, explaining why they were not found in another niche (Fig.
5M). The lumen in these mice was not colonized with bacteria,
while the gentamicin-protected fraction had 103 CFU, suggest-
ing that these mice were resolved with QIR formation. Thus, at
different times during the infection, the urine fraction contains
bacteria shed from the kidneys, planktonic bacteria from the
bladder lumen, bacteria strongly adhered to or within exfoli-
ated epithelial cells, or bacteria otherwise lost from bladder
and kidney niches (Fig. 5I to M).
DISCUSSION
We created 40 isogenic uniquely tagged UPEC strains and
assessed the presence of these bacteria in niches within the
urinary tract over time with a multiplex PCR assay. This ap-
proach allowed us to provide an accurate accounting of the
strains distributed throughout different compartments in the
urinary tract over the course of UTI. By recovering bacteria
from the samples on agar overnight to amplify even rare ge-
netic tags, our approach resulted in a highly sensitive assay that
provided a conservative estimate of the strains present in each
compartment and their distributions throughout the urinary
tract at the time of sampling. Using this molecular approach to
better understand the obstacles in UPEC pathogenesis, we
have revealed a series of population bottlenecks and interac-
tions between distinct populations of the bladder and kidneys
that impact the dynamics of the UPEC population during
infection as a whole.
When C3H/HeN mice are inoculated with 107 CFU UTI89,
103 to 104 CFU invade the bladder epithelium at 1 hpi, and all
of bacterial tags can be accounted for in the bladder intracel-
lular population (Fig. 5G). Subsequently, 3 to 700 IBCs are
formed per bladder by 6 hpi, and as demonstrated herein, each
IBC is derived from a single bacterium that enters into the
cytoplasm of a superficial facet cell (Fig. 1 and 2). Together,
0.1% of the inoculum invades the epithelium, and 2% of the
invasive bacteria successfully form IBCs. The most stringent
population bottleneck observed is between 1 and 24 hpi, cor-
responding to the time frame when a limited number of inva-
sive bacteria have entered into the IBC cycle while innate
immunity is engaged to clear luminal organisms. These dynam-
ics produce a founder effect. The variance of the fraction of
tags present within the bladder epithelium at 6 hpi and in the
whole bladder at 24 hpi (Fig. 2, 3C, 5G) reflects the large
bladder-to-bladder variance in IBC numbers and begins to
reflect the bimodal distribution in infection outcome. The
cause of the variance in IBC numbers is unknown but presum-
ably reflects factors necessary to penetrate the various bottle-
necks described here.
Our experimental data demonstrating the clonality of IBCs
suggest that IBC formation with a concurrent reduction of the
luminal UPEC population places a significant constraint on the
number of organisms progressing through to later stages of
infection. Indeed, modeling clonal IBC formation as the only
pathway by which organisms can persist in the urinary tract fits
the observed data very well and supports this hypothesis (see
Fig. S1 in the supplemental material). Given that IBCs are
clonal, a single IBC can contribute only to the detection of a
single tag. So long as a tag is detected in our PCR assay, we
cannot distinguish whether it was present in one or many IBCs.
Therefore, assuming that tags are equivalent and detection by
PCR is efficient, this is akin to an experiment where for every
IBC, a die with 40 different numbers (each corresponding to a
tag) is cast, and we count how many different numbers were
thrown as a result of all casts of the die. With these assump-
tions, the probability distribution of the number of tags de-
tected (different numbers of the die) given a number of IBCs
formed (number of casts of the die) can be calculated exactly
using a multinomial distribution (see Fig. S1 in the supplemen-
tal material). If there are other pathways to persistence that do
not involve IBC formation (such as persistence exclusively in
the lumen of the bladder), the number of tags detected can be
modeled as additional throws of the die, 1 per each additional
extracellular clone (see Fig. S1A in the supplemental mate-
rial). Given the close fit between the multinomial expectation
(based solely on IBC number) and the observed number of
tags (Fig. 2), if there is another pathway to persistence, its
contributions in terms of diversity are very small and effectively
not measurable in our data. Small, exclusively luminal popu-
lations (not necessarily clonally derived from a single founder)
could be predicted to drastically increase the expected fraction
of tags persisting when low numbers of IBCs are present,
though this is not experimentally observed (see Fig. S1A and
Fig. S2 in the supplemental material). Although it is formally
possible that clonal, extracellular populations contribute to
bacterial diversity within the bladder at 6 hpi, the most likely
interpretation of our data is that by 24 hpi, the extracellular
population is largely a subset of bacteria arising from bacterial
subpopulations that have emerged from other niches, with
IBCs being a major source (Fig. 5I and J).
The outcomes of acute infection are (i) resolution of bacte-
riuria which can be accompanied by the formation of a QIR,
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which can lead to recurrent infection, or (ii) chronic active
cystitis marked by persistent bacteriuria for 7 months, which
presumably reflects extracellular replication of bacteria (20,
40). Our data described above indicate that the strongest pop-
ulation bottlenecks exist within the first 24 hpi. Prior studies of
UPEC mutants with defects in IBC development suggest that
the first-generation IBCs are important for the establishment
of acute cystitis (25, 48).
The studies presented herein have several key implications.
First, in species such as humans, where isolated cystitis is
common, the bottlenecks due to invasion and the IBC cycle
may be even more stringent than observed in our studies in
C3H/HeN mice, because there may be no mixing of bacteria
being shed from the kidneys into the bladder. Inhibitors at the
point of the major bottlenecks within the first 24 h of infection
may significantly attenuate infection, both acute and chronic.
For instance, inhibition of the IBC pathway, either by blocking
IBC formation, development, or dispersal, may alter outcomes
by reducing the number of QIRs and limiting chronic active
cystitis. Combined with a FimH vaccine, invasion inhibitors
may be particularly potent in preventing and treating UTI (19).
A recent study showed that in a urological cohort of women,
UPEC strains isolated from urine from 6/8 patients were not
actively expressing type 1 pili (18). Our results (Fig. 5M) that
60% of strains detected were present only in the urine argue
that these UPEC may indeed reflect strains lost from the
bladder, as they were not detectable in any other urinary tract
niche. Thus, although it is possible that these strains are not
expressing type 1 pili as suggested by the results of Hagan et al.
(18), their existence presumably depended on earlier coloni-
zation events involving type 1 pili and other virulence factors.
Finally, the development and maintenance of genomic changes
by UPEC during UTI may be contingent on the timing of
acquisition of mutations, rearrangements, or deletions in the
genome due to the bottleneck constraints present in the sys-
tem. For instance, a mutant subpopulation obtaining antimi-
crobial resistance to trimethoprim through a mutation in dihy-
drofolate reductase (DHFR) may be extinguished by a
stringent stochastic bottleneck even under circumstances when
the antibiotic is being administered and an antibiotic resistance
mutation provides a selective advantage. This would be ex-
pected to occur if the proportion of the population with that
advantage is sufficiently too small to overcome the inherent
stochastic barriers that eliminate the vast majority of the pop-
ulation and produce a founder effect, likely in this case to arise
from majority members that do not have the advantageous
mutation. Alternatively, hosts in which bacteria more effec-
tively penetrate the early bottlenecks, such as those developing
chronic cystitis where diversity is maintained, may provide pro-
ductive environments for the selection and perpetuation of
adaptive mutations. Thus, diversity and selective evolution may
be constrained by these stochastic mechanisms during cystitis
and/or dramatically favor mutations that facilitate invasion and
IBC formation. Indeed, several genes important for invasion,
IBC formation, and living within host cells were shown to be
under positive selection in UPEC (5, 6).
The findings herein present the hypothesis that an increased
number of IBCs activates a host immune response that predis-
poses to persistent bacteriuria and chronic cystitis. In C3H/
HeN mice, increasing the inoculum to 108 CFU/ml increases
the average number of IBCs formed and increases the percent-
age of mice experiencing persistent bacteriuria (20). Currently,
it is not possible to evaluate these metrics of infection within
the same mouse. Longitudinal monitoring of bacterial popu-
lations in vivo using techniques in development, such as intra-
vital multiphoton microscopy to enumerate acute IBC forma-
tion at 6 hpi and determine bacteriuria and tissue titers at 2
wpi, will provide further resolution to the consequences of
early infection events on subacute and chronic outcomes. Our
findings are especially relevant for mucosal pathogens that
have to transit through potential population bottlenecks simi-
lar to those described in this work (9, 27, 28). Finally, the
methodology described herein could be ideal to analyze pop-
ulation bottlenecks, niche occupation, and clonality by other
bacterial pathogens of mucosal sites.
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